UK markets closed

Anagenics Limited (AN1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
At close: 01:44PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
10,196
9,113
9,235
5,816
7,381
Cost of revenue
5,449
4,702
4,170
2,113
2,534
Gross profit
4,748
4,412
5,065
3,704
4,847
Operating expenses
Research development
-
21.193
110.347
118.793
849.019
Selling general and administrative
6,553
5,876
8,229
5,893
7,199
Total operating expenses
7,493
6,747
9,627
8,228
11,279
Operating income or loss
-2,746
-2,336
-4,562
-4,524
-6,432
Interest expense
63.887
31.844
69.86
54.756
71.257
Total other income/expenses net
215.528
611.479
464.809
343.242
1,147
Income before tax
-2,580
-1,734
-3,644
-3,760
-4,818
Income tax expense
0.001
7.87
4.783
45.049
89.473
Income from continuing operations
-2,580
-1,742
-3,649
-3,805
-4,907
Net income
-3,160
-2,667
-3,649
-3,387
-4,907
Net income available to common shareholders
-3,160
-2,667
-3,649
-3,387
-4,907
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Basic average shares
265,950
265,950
211,374
142,533
105,584
Diluted average shares
265,950
265,950
211,374
142,533
105,584